Gumlink takes over 50% stake in Tab Labs
The joint venture is among the first initiatives in Gumlink’s nutraceutical strategy for the future involving strategic collaborations with various industry partners, as announced in January this year.
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
DKSH’s Business Unit Performance Materials is a specialty chemicals distributor and a provider of Market Expansion Services for performance materials. The Business Unit sources, develops, markets and distributes